NE-induced activation of ADRB2 signaling could be particularly relevant for prostate cancer with neuroendocrine differentiation and especially for castration resistant neuroendocrine prostate cancer (CRPC-NE) [5,63]. This evidence concerns the gene ADRB2 and prostate carcinoma.